Results 101 to 110 of about 11,369 (213)

Perbandingan Model Pertumbuhan Tumor Dengan Metode Pengobatan Virotherapy Dan Radiovirotherapy [PDF]

open access: yes, 2011
In this paper, the study was about the stability analysis and comparison of tumour growth model under the Virotherapy and Radiovirotherapy treatments. The effect of parameter values on the tumor growth for both methods presented in numerical solutions ...
Gumilang, Fajar
core   +1 more source

Targeting oncogenic fusion-driven NUT carcinoma with CRISPR-Cas9 genome editing

open access: yesMolecular Therapy: Oncology
NUT carcinoma (NC) is a highly aggressive malignancy characterized by an oncogenic fusion gene incorporating the NUTM1 gene. To date, no established treatment options exist.
Maxim F. Carle   +7 more
doaj   +1 more source

Turning Cold Tumors Into Hot Tumors: Implications for Cancer Therapy

open access: yesMedComm, Volume 7, Issue 8, August 2026.
Barrier‐defined strategies for cold‐to‐hot tumor conversion. Cold tumors include immune‐desert and immune‐excluded states marked by poor antigen visibility, limited T‐cell priming, stromal or vascular exclusion, metabolic stress and suppressive immune programs.
Xiao Ge   +5 more
wiley   +1 more source

Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial [PDF]

open access: yes
Correction to: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 ...
Colman, Howard   +38 more
core   +1 more source

Applications of Oncolytic Virotherapy in Malignant Tumors

open access: yes
Oncolytic virotherapy, an emerging cancer immunotherapy modality, has attracted much attention in recent years due to its power to selectively infect and eradicate tumor cells while simultaneously activating host anticancer immune responses.
Yining Wang
core   +1 more source

The oncolytic vesicular stomatitis virus VSV-GP shows profound oncolytic activity in NUT-carcinoma cell lines

open access: yesMolecular Therapy: Oncology
NUT carcinoma (NC) is a rare, yet aggressive disease (median survival of 6.5 months) of the young defined by a translocation of the nuclear protein in testis gene 1 (NUTM1).
Rieka C. Buchenau   +13 more
doaj   +1 more source

Human Menstrual Blood-Derived Mesenchymal Stem Cells as Potential Cell Carriers for Oncolytic Adenovirus

open access: yesStem Cells International, 2017
Antitumor efficacy of systemically administered oncolytic adenoviruses (OAdv) is limited due to diverse factors such as liver sequestration, neutralizing interactions in blood, elimination by the immune system, and physical barriers in tumors.
R. Moreno   +6 more
doaj   +1 more source

Release the hounds: virotherapy with immunotherapy [PDF]

open access: yesBlood, 2016
In this issue of Blood, Shen et al demonstrate that the vesicular stomatitis virus (VSV)-murine interferon β (IFNβ)-sodium iodide symporter (NIS) (VSV-mIFNβ-NIS) oncolytic virus has significant antileukemia activity, which is enhanced when combined with an anti-programmed death-ligand 1 (PD-L1) antibody.
openaire   +2 more sources

Supplementary Figure 4 from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer

open access: yes, 2010
Supplementary Figure 4 from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid ...
Yasuo Urata (157765)   +9 more
core   +1 more source

Supplementary Figure 3 from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer

open access: yes, 2010
Supplementary Figure 3 from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid ...
Yasuo Urata (157765)   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy